Start-up
Trestle Biotherapeutics, Inc.
About Trestle Biotherapeutics
Trestle Biotherapeutics, Inc. is a pre-clinical stage company developing bioengineered therapies for patients living with end stage renal disease. Once implanted, these bioengineered stem cell-derived tissues will get patients off dialysis, delay their need for transplantation, and one day become replacement organs.
Facts about Trestle Biotherapeutics
Facts about Trestle Biotherapeutics
- Founding: 2020
- Focus : Service
- Industry : Biotechnology